{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:05:30Z","timestamp":1781719530111,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd001909","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000}}],"reference-count":55,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001909.pub2","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T19:04:16Z","timestamp":1466708656000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lamotrigine add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"Sridharan","family":"Ramaratnam","sequence":"first","affiliation":[{"name":"The Nerve Centre; Department of Neurology; 5\/1 Rajachar Street T Nagar Chennai Tamil Nadu India 600017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Panebianco","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"10.1002\/14651858.CD001909.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Baulac M Leon T O'Brien TJ Whalen E Barrett J A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures Epilepsy Research 2010 10 9","DOI":"10.1016\/j.eplepsyres.2010.05.008"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0920-1211(89)90007-7","article-title":"Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy","volume":"4","author":"Binnie","year":"1989","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1996.tb07060.x","article-title":"Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures","volume":"94","author":"Boas","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD001909.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001909.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1528-1157.1989.tb05309.x","article-title":"Controlled trial of lamotrigine (lamictal) for refractory partial seizures","volume":"30","author":"Jawad","year":"1989","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0920-1211(90)90099-H","article-title":"A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures","volume":"7","author":"Loiseau","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. US Lamotrigine Protocol 0.5 Clinical Trial Group","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001909.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1212\/01.wnl.0000277698.33743.8b","article-title":"Lamotrigine extended-release as adjunctive therapy for partial seizures","volume":"69","author":"Naritoku","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1212\/01.wnl.0000285493.08622.35","article-title":"Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months","volume":"70","author":"Pi\u00f1a-Garza","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0896-6974(95)00034-B","article-title":"Lamotrigine: a six-month, placebo-controlled, safety and tolerance study","volume":"8","author":"Schachter","year":"1995","journal-title":"Journal of Epilepsy"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp.56.5.448","article-title":"Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures","volume":"56","author":"Schapel","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001909.pub2-BIB0013|cit13","first-page":"66","article-title":"Add-on treatment with lamotrigine for intractable partial epilepsy: a placebo-controlled, cross-over trial","volume":"34 Suppl","author":"Schmidt","year":"1993","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001909.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1528-1157.1993.tb02417.x","article-title":"Outcomes of add-on treatment with lamotrigine in partial epilepsy","volume":"34","author":"Smith","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Biton V Di Memmo J Shukla R Lee YY Poverennova I Demchenko V Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study Epilepsy & Behavior 2010 352 8","DOI":"10.1016\/j.yebeh.2010.07.022"},{"issue":"5","key":"10.1002\/14651858.CD001909.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40261-013-0070-4","article-title":"Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials","volume":"33","author":"Biton","year":"2013","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD001909.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2710.2012.01351.x","article-title":"Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics","volume":"37","author":"Brzakovic","year":"2012","journal-title":"Journal of Clinical Pharmacy & Therapeutics"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0018|cit18","first-page":"135","article-title":"Controlled trial of lamotrigine for the treatment of refractory partial seizures","volume":"45 Suppl 3","author":"Carignani","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0019|cit19","first-page":"124","article-title":"Controlled trial of lamotrigine for the treatment of refractory partial seizures","volume":"47 Suppl 3","author":"Carignani","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001909.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ane.12086","article-title":"Indirect comparison of clobazam and other therapies for Lennox-Gastaut Syndrome","volume":"128","author":"Cramer","year":"2013","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1-2","key":"10.1002\/14651858.CD001909.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eplepsyres.2012.03.015","article-title":"Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies","volume":"101","author":"French","year":"2012","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1002\/14651858.CD001909.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S1984-82502012000100011","article-title":"Interchangeability among therapeutic equivalents of lamotrigine: evaluation of quality of life","volume":"48","author":"Girolineto","year":"2012","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD001909.pub2-BIB0023|cit23","first-page":"100","article-title":"Pragmatic intent-to-treat analysis for lamotrigine extended release adjunctive therapy in patients with intractable partial seizures","volume":"49","author":"Hammer","year":"2008","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD001909.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/11634260-000000000-00000","article-title":"Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study","volume":"26","author":"Hartung","year":"2012","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1002\/14651858.CD001909.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yebeh.2012.11.052","article-title":"The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting","volume":"26","author":"Helmstaedter","year":"2013","journal-title":"Epilepsy & Behaviour"},{"issue":"17","key":"10.1002\/14651858.CD001909.pub2-BIB0026|cit26","first-page":"1174","article-title":"Efficacy and safety of the combined therapy of valproic acid and lamotrigine for epileptics","volume":"92","author":"Kang","year":"2012","journal-title":"Zhonghua yi xue za zhi"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD001909.pub2-BIB0027|cit27","first-page":"369","article-title":"An analysis of the efficacy of lamotrigine extended-release adjunctive therapy in subjects with partial epilepsy by number of concomitant AEDs","volume":"48","author":"Montouris","year":"2007","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001909.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3805\/jjes.25.425","article-title":"[Single-blind and controlled comparative study of lamotrigine with zonisamide for refractory pediatric epilepsy]","volume":"25","author":"Ohtahara","year":"2007","journal-title":"Journal of the Japan Epilepsy Society"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(90)90077-9","article-title":"A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy","volume":"6","author":"Sander","year":"1990","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD001909.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1684\/epd.2014.0650","article-title":"Early add-on treatment vs alternative monotherapy in patients with partial epilepsy","volume":"16","author":"Semah","year":"2014","journal-title":"Epileptic disorders"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jnnp.57.8.921","article-title":"Vigabatrin and lamotrigine in refractory epilepsy","volume":"57","author":"Stolarek","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001909.pub2-BIB0032|cit32","first-page":"118","article-title":"Evaluation of sudden unexpected death in epilepsy (SUDEP) occurring in lamotrigine (LTG) clinical trials","volume":"53","author":"Tomson","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD001909.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1528-1167.2012.03689.x","article-title":"Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0034|cit34","first-page":"97","article-title":"Use of lamotrigine as adjunctive therapy in patients with mental retardation and epilepsy. An interim analysis of a double blind study with evaluation of behavioural effects","volume":"41(Suppl Floren","author":"Veendrick-Meekes","year":"2000","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001909.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1248\/bpb.35.487","article-title":"Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients","volume":"35","author":"Yamamoto","year":"2012","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0036|cit36","first-page":"230","article-title":"Neuropsychological assessment in lamotrigine treated epileptic patients","volume":"28","author":"Banks","year":"1991","journal-title":"Clinical and Experimental Neurology"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-94-017-8914-1_24","article-title":"What are the arguments for and against rational therapy for epilepsy?","volume":"813","author":"Barker-Haliski","year":"2014","journal-title":"Advances in Experimental Medicine & Biology"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the national general practice study of epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001909.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001909.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League A Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0041|cit41","unstructured":"McMaster University GRADEpro. [Computer program on www.gradepro.org]. Version [insert date of use] 2014"},{"issue":"3","key":"10.1002\/14651858.CD001909.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935 -1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0043|cit43","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0045|cit45","article-title":"Lamotrigine","volume-title":"Mechanisms of action in antiepileptic drugs","author":"Leach","year":"1995"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0046|cit46","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from http:\/\/handbook.cochrane.org\/"},{"issue":"3","key":"10.1002\/14651858.CD001909.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-6147(00)01974-X","article-title":"Current status and future directions in the pharmacotherapy of epilepsy","volume":"23","author":"Loscher","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"issue":"11","key":"10.1002\/14651858.CD001909.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1517\/14656566.2014.922544","article-title":"Pharmacotherapy of focal epilepsy","volume":"15","author":"Lyer","year":"2014","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"8","key":"10.1002\/14651858.CD001909.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14656566.2012.665875","article-title":"Lamotrigine use in pregnancy","volume":"13","author":"Moore","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD001909.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/14728214.2013.750294","article-title":"Emerging drugs for focal epilepsy","volume":"18","author":"Mula","year":"2013","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"4","key":"10.1002\/14651858.CD001909.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002896.pub2","article-title":"Vagus nerve stimulation for partial seizures","author":"Panebianco","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001909.pub2-BIB0052|cit52","unstructured":"5.3. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD001909.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2012.05.024","article-title":"Lamotrigine in epilepsy, pregnancy and psychiatry - a drug for all seasons?","volume":"20","author":"Vajda","year":"2013","journal-title":"Journal of Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD001909.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010541.pub2","article-title":"Surgery for epilepsy","author":"West","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001909.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001909","article-title":"Lamotrigine add-on for drug-resistant partial epilepsy","author":"Ramaratnam","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001909.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001909.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:06:56Z","timestamp":1628543216000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001909.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001909.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001909.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}